Blueprint Medicines Corporation
BPMC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$67,089 | -$506,984 | -$557,517 | -$644,085 |
| Dep. & Amort. | $16,291 | $11,665 | $11,735 | $6,479 |
| Deferred Tax | $0 | $0 | $0 | $1,361 |
| Stock-Based Comp. | $108,911 | $92,672 | $98,971 | $91,630 |
| Change in WC | $0 | -$41,128 | -$53,769 | -$23,680 |
| Other Non-Cash | -$250,699 | $6,928 | -$1,697 | $269,642 |
| Operating Cash Flow | -$192,586 | -$436,847 | -$502,277 | -$298,653 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4,630 | -$16,062 | -$8,919 | -$261,241 |
| Net Acquisitions | $0 | $0 | $0 | $258,152 |
| Inv. Purchases | -$966,431 | -$766,363 | -$489,705 | -$655,449 |
| Inv. Sales/Matur. | $923,560 | $1,056,465 | $349,373 | $690,830 |
| Other Inv. Act. | $0 | $0 | -$290 | -$258,152 |
| Investing Cash Flow | -$47,501 | $274,040 | -$149,541 | -$225,860 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $146,973 | $97,933 | $137,786 | $0 |
| Stock Issued | $48,936 | $0 | $8,196 | $50,716 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $77,202 | -$44 | $424,024 | $50,716 |
| Financing Cash Flow | $273,111 | $119,225 | $561,810 | $50,716 |
| Forex Effect | -$909 | $202 | -$207 | -$888 |
| Net Chg. in Cash | $32,115 | -$43,380 | -$90,215 | -$474,685 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $81,524 | $124,904 | $215,119 | $689,804 |
| End Cash | $113,639 | $81,524 | $124,904 | $215,119 |
| Free Cash Flow | -$197,216 | -$452,909 | -$511,196 | -$559,894 |